Pharmacokinetics and Pharmacodynamics of Prusogliptin (DBPR108), a Once-Daily Dipeptidyl Peptidase-4 Inhibitor, in Patients with Type 2 Diabetes
普鲁格列汀（DBPR108，一种每日一次的二肽基肽酶-4抑制剂）在2型糖尿病患者中的药代动力学和药效学研究
期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-025-01501-8
Liu, Wenfang; Yang, Kexu; Lin, Yang; Lu, Chunyan; Liu, Jingyi; Zhou, Huan; Wang, Juan; Zhang, Tianhao; Yao, Lingli; Qi, Huanhuan; Zhang, Xiaofang; Jia, Rui; Li, Xiaoli; Jing, Shan
